Commercializing & Scaling Innovation: The $14 Billion Playbook

Turning “Scaling the Beta” risks into an “Investable Proposition.”

Work With Kevin

15 Years Entrepreneurial Experience

15 Years C-Suite Experience

As Seen On:

Kevin’s advisory practice gives your organization the $15bn playbook

Commercializing Innovation

95% of all innovations fail to gain traction… understanding the reasons for this significantly improves your chances of launch success. Winning with your new product in the real world is where all value is created.

Senior Team Strategic Alignment

According to leading academic studies, lack of senior team alignment is the biggest statistical predictor of sub-par organizational performance.

Marketing & Branding

Many organizations treat branding as decoration. In actuality, a brand that is clearly unique, different, better, and special is highly correlated with product and organizational success.

Leadership

Human beings are attracted to working for organizations with a purpose that’s greater than themselves. Unlocking this for your organization is a powerful new tool in your success portfolio.

Fundraising

Most innovations fail due to a lack of capital. Understanding the nuances of an investible proposition is key to product launch success.

Company Turnaround

Smart people tend to overcomplicate things. Customers who prefer your competitor’s offering are the root of all product and organizational performance issues.

“Kevin had an amazing ability to translate powerful quantitative research into totally actionable results for some of the greatest brands in the world”

Kevin Clancy PhD

Founder and Chairman

Copernicus Marketing Consulting

“Kevin brings a passion, energy and intelligence to his strategy and innovation engagements that simply has to be experienced!”

Regina Lewis PhD

Professor, Former SVP Research

University of Alabama, IHG Intercontinental Hotel Group

“Kevin seamlessly integrated into my organization on a multi-year assignment that resulted in truly explosive growth for the company”

Chuck Feltz

Managing Partner, Former President

Feltz Associates, Deluxe

“Kevin brings one of the nation’s most innovative minds to real world businesses that need to successfully commercialize transformative ideas”

Andy Pierce

Partner, Former President

Bain and Company, Prophet

Kevin’s Blueprint for Value Creation

Influencing Preference is the Centerpiece of all Value Creation

Learn More

Most Organizations Are Not Hardwired For Transformative Innovation

Learn More

Culture is the Secret Sauce for World-Class Outcomes

Learn More

Raising Capital Supports All Growth & Innovation

Learn More

Kevin focuses on mid-cap companies and startups that have completed their Series A funding.

Companies Kevin Has Advised

About Kevin

I treat business as biology. My journey began by launching formaldehyde-free insulation at Johns Manville, followed by founding Green Mountain Energy (a $110M exit). After advising giants like BMW via KH Innovations, I became Keurig’s Chief Innovation Officer, helping scale a $14B global leader. Today, I lead Cambio Roasters. I don’t just market brands; I use the “Rx of Preference” to diagnose your strategy and engineer the neurochemistry of “Yes.”

Get To Know Kevin

FAQ

Why do CEOs engage you as a Trusted Advisor and "Objective Mirror"?
CEOs at the highest levels require a peer who has managed the same high-stakes pressure they face daily.

I provide a “Founder-to-Fortune” playbook, serving as a strategic sounding board to help leaders navigate complex transitions that internal teams—often hampered by corporate politics—cannot see clearly.

My role is to diagnose “Pleasure-Agnostic” blind spots in the current strategy and prescribe the specific architecture required for market dominance.
What makes your "Strategic Partnership" different from traditional management consulting?
Traditional consultancies often focus on supply chain and efficiency, remaining “Pleasure-Agnostic” to the biological reality of the consumer.

As a Hybrid Leader, I bridge the gap between “Founder Grit” and “Fortune 500 Governance,” leveraging 15 years in the C-suite and 15 years as a serial entrepreneur.

I don’t just provide advice; I architect the “Biology of a Brand” to ensure it triggers the specific neurochemicals—Dopamine and Endorphins—that drive consistent preference.
How do you serve as an "Enterprise Architect" for commercializing innovation?
I help large organizations de-risk their growth by implementing my “Last Experiment First” methodology.

Instead of “Scaling the Beta” and risking millions on an unproven idea, I validate the “Dopamine Trigger” of the concept at its most “Unadulterated Glory” before capital is fully deployed.

I ensure every new project is structured as an “Investable Proposition” that manages stakeholder “Loss Aversion” while maximizing the anticipation of reward.
How does "Business Biology" create shareholder value at a $14 billion scale?
Business is not finance; it is biology.

Humans are biologically hardwired to buy products that trigger pleasure chemicals and reject those that trigger Cortisol (Stress and Confusion).

I applied this principle to scale Keurig into a $14 billion global leader and place brewers in 33 million homes, proving that “Business Art” is a strategic necessity for massive value creation.
How do you help CEOs address cultural stagnation and "Tall Poppy Syndrome"?
I work with the C-suite to identify and cure “Tall Poppy Syndrome”—a corporate culture that cuts down high performers to maintain the status quo.

I help leaders hardwire their organizations for transformation by treating every touchpoint as “Galleriable” and hiring “Genuine Big Hearts” who use curiosity as a primary KPI.

We shift the culture from one of risk-avoidance to one that treats business strategy as a high-stakes art project.

Give your organization the $15bn Playbook

Turn “Scaling the Beta” risks into an “Investable Proposition.”

Let's Talk